SCHEMBL31040360

SCHEMBL31040360

CN(C)C(=O)[C@H]1CCCCN1C1CCN(C(=O)OC(C)(C)C)CC1

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.49
EPHX1 P07099 1/20 0.47
RECQL P46063 1/20 0.41
HSD17B10 Q99714 1/20 0.41
PREP P48147 1/20 0.40
USP2 O75604 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
HCAR1 Q9BXC0 1/20 0.39
GPR119 Q8TDV5 2/20 0.39
USP30 Q70CQ3 1/20 0.39
ABL1 P00519 1/20 0.38
RIN1 Q13671 1/20 0.38
KDM4E B2RXH2 1/20 0.38
MAPT P10636 1/20 0.38
THRB P10828 1/20 0.38
PTPN2 P17706 1/20 0.38
PTPN1 P18031 1/20 0.38
PTPN6 P29350 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18923615 0.85 HPGD (0.52) HPGDEPHX1RECQLHSD17B10PREP
SCHEMBL19273232 0.85 HPGD (0.52) HPGDEPHX1RECQLHSD17B10PREP
SCHEMBL31040357 0.83 EPHX1 (0.51) HPGDEPHX1RECQLHSD17B10PREP
SCHEMBL17001945 0.82 EPHX1 (0.50) HPGDEPHX1RECQLHSD17B10PREP
SCHEMBL18923614 0.82 EPHX1 (0.50) HPGDEPHX1RECQLHSD17B10PREP
SCHEMBL20292210 0.81 CNR2 (0.33) SMN1; SMN2
SCHEMBL19947116 0.80 HPGD (0.55) HPGDEPHX1RECQLPREPUSP2
SCHEMBL2479150 0.80 HPGD (0.55) HPGDEPHX1RECQLPREPUSP2
SCHEMBL17001789 0.79 EPHX1 (0.49) HPGDEPHX1RECQLHSD17B10USP2
SCHEMBL17001995 0.79 EPHX1 (0.49) HPGDEPHX1RECQLHSD17B10USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4714446-A2 PHARMACEUTICAL COMPOUNDS Nxera Pharma UK Limited (GB) 2026-03-25 EP disclosed
EP-4413985-A2 PHARMACEUTICAL COMPOUNDS Nxera Pharma UK Limited (GB) 2024-08-14 EP disclosed